Tag: Phase-2
United States opens clinical trial enrollment for treatment of progressive Parkinsonian...
Alterity Therapeutics launches ATH434 Phase 2 Clinical Trial in the United States for the treatment of individuals with Multiple System Atrophy
DCGI green signal to COVAXIN’s Phase II/III clinical trial in 2-18...
Hyderabad based Bharat Biotech to conduct clinical trials in 525 healthy volunteers........................
Sun Pharma initiates Phase 2 clinical trial of Psoriasis drug
SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis, are also expected to be initiated soon......................
Sun Pharma seals US$ 145 million deal with SPARC over potential...
The two companies have announced a worldwide licensing agreement on the development and commercialization of SCD-044 which is being evaluated as a potential oral treatment for atopic dermatitis, psoriasis and other auto-immune disorders.............
Vyome Therapeutics begins phase 2 trial of its drug for acne...
The company has dosed the first patient in its Phase 2 trial of the Company’s lead clinical candidate, VB-1953, for the treatment of moderate to severe inflammatory acne vulgaris......................
Zydus Cadila begins phase-2 trial of drug to cure anaemia in...
Zyani1, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), is being tested as a viable treatment for anaemia associated with chronic kidney disease (CKD)...........
India to soon launch its indigenously developed vaccine against Leprosy
Developed by Dr G P Talwar, Founding Director of National Institute of Immunology, this exclusive vaccine for leprosy will be piloted in five districts....